Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
Sales | 135 | 30 | 0 | 30 | 150 |
Gross Profit | 135 | 30 | N/A | 30 | 150 |
Operating Expenses | 4,588 | 1,636 | 0 | 808 | 855 |
Operating Income | -4,453 | -1,606 | N/A | -778 | -705 |
Interest Expense | 4 | 14 | 0 | 28 | 20 |
Other Income | -637 | -43 | 0 | -7 | -8 |
Pre-tax Income | -5,094 | -1,663 | 0 | -813 | -733 |
Net Income Continuous | -5,094 | -1,663 | N/A | -813 | -733 |
Net Income | $-5,094 | $-1,663 | $N/A | $-813 | $-721 |
EPS Basic Total Ops | -22.70 | -4.50 | N/A | -2.20 | -2.00 |
EPS Basic Continuous Ops | -13.87 | -4.53 | N/A | -2.21 | -2.00 |
EPS Diluted Total Ops | -22.70 | -4.50 | N/A | -2.20 | -2.00 |
EPS Diluted Continuous Ops | -13.87 | -4.53 | N/A | -2.21 | -2.00 |
EBITDA(a) | $-4,428 | $-1,597 | $N/A | $-766 | $-705 |